Pathology · Hematological Malignancies (Leukemias, Lymphomas, Myeloma)

A 70-year-old man with multiple myeloma has del(17p13.1) detected by FISH. This deletion involves the TP53 locus and carries which prognostic significance?

  • A High-risk myeloma associated with inferior outcomes even with novel agent-based therapy
  • B Standard-risk myeloma with excellent response to bortezomib
  • C Indicates smoldering myeloma that does not require treatment
  • D Favorable cytogenetics comparable to hyperdiploidy
Correct answer: A. High-risk myeloma associated with inferior outcomes even with novel agent-based therapy

Explanation

Deletion of 17p13.1 (TP53 locus) is classified as high-risk cytogenetics in multiple myeloma by the Revised International Staging System (R-ISS) and is associated with shorter progression-free and overall survival even with bortezomib-based or lenalidomide-based regimens. Other high-risk FISH findings include t(4;14), t(14;16), and gain(1q). Hyperdiploidy (odd-numbered chromosomal gains) is favorable.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs

See all Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs →